# An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

> **NCT04641481** · PHASE3 · UNKNOWN · sponsor: **Bharat Biotech International Limited** · enrollment: 25800 (actual)

## Conditions studied

- Covid19
- SARS-CoV Infection

## Interventions

- **BIOLOGICAL:** BBV152
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04641481
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-16
- **Primary completion:** 2021-01-08
- **Final completion:** 2022-12
- **Target enrollment:** 25800 (ACTUAL)
- **Last updated:** 2021-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04641481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04641481, "An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04641481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*